研究文章
PTPRH的高表达与人类肺腺癌的预后不良有关
表1
PTPRH表达和临床病理特征之间的联系LUAD TCGA从数据库。
|
|
低PTPRH |
高PTPRH |
价值 |
| (
) |
(
) |
|
| 年龄(年) |
|
|
|
|
|
103例(43.3%) |
107例(45.1%) |
0.75 |
|
|
135例(56.7%) |
130例(54.9%) |
|
| 性别 |
|
|
|
| 女 |
135例(56.7%) |
119例(50.2%) |
0.183 |
| 男性 |
103例(43.3%) |
118例(49.8%) |
|
| T |
|
|
|
| T1 |
94例(39.5%) |
68例(28.7%) |
0.0073 |
| T2 |
124例(52.1%) |
127例(53.6%) |
|
| T3 |
14 (5.9%) |
30 (12.7%) |
|
| T4 |
6 (2.5%) |
12 (5.1%) |
|
| N |
|
|
|
| N0 |
168例(70.6%) |
145例(61.2%) |
0.194 |
| N1 |
39 (16.4%) |
51 (21.5%) |
|
| N2 |
30 (12.6%) |
40 (16.9%) |
|
| N3 |
1 (0.4%) |
1 (0.4%) |
|
| 阶段 |
|
|
|
| 阶段我 |
143例(60.1%) |
113例(47.7%) |
0.0335 |
| 第二阶段 |
53 (22.3%) |
64例(27.0%) |
|
| 第三阶段 |
35 (14.7%) |
45 (19.0%) |
|
| 四期 |
7 (2.9%) |
15 (6.3%) |
|
|
|
